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Reactive oxygen species and aldehyde dehydrogenase
activity in Hodgkin lymphoma cells
Jun-ichiro Ikeda1, Suhana Mamat1,2, Tian Tian1, Yi Wang1, Wenjuan Luo1,3, Nur Rahadiani1, Katsuyuki Aozasa1
and Eiichi Morii1
Tumor cells with tumorigenic potential might be limited to a small population of cells, called cancer-initiating cells (CICs).
CICs efficiently form colonies in vitro, yield both CIC and non-CIC populations, maintain reactive oxygen species (ROS) at
low levels, show high aldehyde dehydrogenase (ALDH) activity, and are mostly in a quiescent state of the cell cycle. CICs
of Hodgkin lymphoma (HL) are small in size, with low levels of ROS. The relationship between ROS level and ALDH activity
in CICs was examined in HL cell lines. ROS-low and ALDH-high populations formed colonies in semi-solid cultures more
efficiently than ROS-high and ALDH-low populations. ALDH-high populations yielded both ALDH-low and -high popu-
lations, whereas ALDH-low populations rarely yielded an ALDH-high population. The number of cells in a quiescent
state was significantly greater in ROS-low than in ROS-high cells, whereas that of ALDH-high and ALDH-low cells was
comparable to each other. These findings show that ALDH-high and ROS-low cells share CIC-like potential, but they
differ in their cell cycle status, suggesting that CICs are comprised of cells with heterogeneous characteristics.
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Tumors consist of heterogeneous cell populations derived
from a single clone. Recently, it has been demonstrated that
tumor cells with tumorigenic potential are limited to a small
population of cells, called cancer-initiating cells (CICs). CICs
are present in several tumors, such as leukemia, breast, brain,
and colon cancers.1–8 CICs yield both CICs and non-CICs,
whereas non-CICs rarely yield CICs.1,5 CICs efficiently efflux
anti-tumor chemicals, form colonies in semi-solid culture,
and degrade reactive oxygen species (ROS) that are generated
upon radiation-induced apoptosis.1–9
Recent studies have pointed to high aldehyde dehydro-
genase (ALDH) activity as a candidate CIC characteristic.10–20
ALDH oxidizes retinol to retinoic acid in the early stages of
stem cell differentiation.11 High ALDH activity is detected
in both physiological stem cells, such as hematopoietic and
neural stem cells,21,22 and CICs of human multiple myeloma,
acute myeloid leukemia, and cancers of the lung and
breast,10,12–17 indicating that ALDH activity may be a
common marker for both normal and malignant stem cell
populations. To date, information on ALDH activity in CICs
of malignant lymphomas is extremely limited.
The cellular origin of Hodgkin lymphoma (HL) had been
controversial; however, recent molecular biology studies have
revealed that HL is mostly a neoplasia of B lymphocytes.23,24
HL can be diagnosed by the presence of multinucleated Reed-
Sternberg (RS) cells and mononuclear Hodgkin cells inter-
mingled with small lymphocytes and various inflammatory
cells. They are regarded as pathognomonic for HL and share
the expression of some cell markers with Hodgkin cells, such
as CD15 and CD30, although the proliferative potential of RS
cells was reported to be lower than that of Hodgkin cells.25 To
date, markers that can differentiate Hodgkin cells from RS
cells have not been established.
We recently reported that HL cell lines, L1236 and L428,
were composed of two types of cells: cells with a single nu-
cleus (S) that resemble Hodgkin cells and those with multiple
nuclei (M) that resemble RS cells.26 S cell cultures yielded
both S and M cells, whereas M cell cultures yielded only
M cells. When cultured in methylcellulose or inoculated
into NOD/SCID mice, colony numbers and tumor sizes
were larger for S than for M cells. The concentration of
intracellular ROS was low in a portion of S cells that
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abundantly expressed FoxO3a, a transcription factor regu-
lating ROS-degrading enzymes. These ROS-low S cells were
tumorigenic and possessed CIC-like characteristics.
Jones et al27 reported that cell lines and circulating B cells
from HL patients contained a limited number of clonal
ALDH-high B cells that might initiate HL. However, a
correlation between ROS levels and ALDH activity has not
yet been determined in any type of tumor, including HL.
Here, ALDH activity was examined in HL cell lines with
regard to tumorigenic potential. Although both high ALDH
activity and low ROS levels may be candidate CIC markers,
the present study revealed that the cell cycle status among
ALDH-high and ROS-low cells varied, suggesting hetero-
geneity of CIC-like populations.
MATERIALS AND METHODS
Cell Lines
Hodgkin lymphoma cell lines, L428 and L1236, were
purchased from Deutsche Sammlung von Mikroorganismen
and Zellkulturen (Braunschweig, Germany). Cells were
cultured in RPMI 1640 (Sigma, St Louis, MO, USA) sup-
plemented with 10% fetal calf serum (FCS; Nippon Bio-
SupplyCenter, Tokyo, Japan). A portion of cultured cells was
cytospun on poly-L-lysine-coated glass slides at 1500 rpm
for 3min and stained with Giemsa solution. As previously
reported,26 cells with a single nucleus or a multinucleus (more
than two nuclei) were named S and M cells, respectively.
Isolation of ALDH-Low and ALDH-High Cells
To isolate the cell population with high ALDH enzymatic acti-
vity, the Aldefluor kit (Stem Cell Technologies, Vancouver, BC,
Canada) was used, according to the manufacturer’s instruc-
tions. Briefly, cells were suspended in Aldefluor assay buffer
containing ALDH substrate and BODIPY–aminoacetaldehyde
(BAAA). The BAAAwas taken up by living cells and converted
by intracellular ALDH into BODIPY–aminoacetate, which
yields bright fluorescence. The brightly fluorescent ALDH-
expressing cells were detected with a FACS Calibur or
FACS Aria II (BD Biosciences, Franklin Lakes, NJ, USA). As a
negative control, cells were stained under identical conditions
with the specific ALDH inhibitor diethylaminobenzaldehyde
(DEAB; Sigma, St Louis, MO, USA). Data were analyzed by
Cell Quest software (BD Biosciences). In HL cell lines, cells
with bright and no or faint fluorescence were defined as
ALDH-high and ALDH-low, respectively.
In Vitro Colony Formation Assay
A total of 5000 suspended cells were plated in culture dishes
with 1ml methylcellulose-containing Dulbecco’s Modified
Eagle’s Medium (DMEM) supplemented with 15% FCS. The
number of colonies was counted on day 14.
Assay for Intracellular ROS Level
Cells were incubated with 10 mM of 5-(and-6)-chloromethyl-
20,70-dichlorodihydrofluorescein diacetate, acetyl ester
(CM-H2DCFDA, Invitrogen) at 37 1C for 20min. Dead cells
were stained with propidium iodide (PI). ROS-high cells
were stained in green and dead cells in red. At least 200 of
S and M cells, respectively, were examined, and the propor-
tion of ROS-high viable cells was counted.
Isolation of ROS-Low and ROS-High Cells
To isolate the cell population with high ROS activity, cells
were incubated with 10 mM CM-H2DCFDA at 37 1C for
20min. Dead cells were stained with PI. Brightly fluorescent
cells were detected with a FACS Calibur or FACS Aria II. As a
negative control, cells were left unstained under identical
conditions. Data were analyzed using Cell Quest software. In
HL cell lines, cells with bright and no or faint fluorescence
were defined as ROS-high and ROS-low, respectively.
Flow Cytometry and Real-Time Quantitative Reverse
Transcription-Polymerase Chain Reaction (qRT-PCR)
Cells were stained with CM-H2DCFDA, and ROS-high and
-low cells were sorted with a FACSAria II. Total RNA was
extracted from sorted cells using the RNeasy RNA extraction
kit (Qiagen, Valencia, CA, USA), according to the manu-
facturer’s protocol. cDNA was synthesized using oligo
(dT) primers and SuperScript III reverse transcriptase
(Invitrogen). qRT-PCR was performed with an ABI PRISM
7700 instrument (Applied Biosystems, Foster City, CA, USA)
using Taqman probe/primer sets specific for human FoxO3a,
ALDH1A1, ALDH3A1, and Bcl-6. GAPDH was used as a
reference for gene amplification (Applied Biosystems). Cells
were stained with antibodies against CD20, CD27, CD30,
immunoglobulin (Ig)k, and Igl (BD Biosciences), and were
analyzed with a FACS Canto II (BD Biosciences).
Immunoglobulin Gene Structure
Genomic DNA of ALDH-high and ALDH-low cell popula-
tions was obtained and used for gene rearrangement analysis
according to the BIOMED-2 protocol.28 The amplified
products were subject to capillary electrophoresis, and the
pattern was compared between these two populations.
Immunocytochemistry for FoxO3a and Ki-67
FoxO3a and Ki-67 expression was immunocytochemically
examined with anti-FoxO3a (Cell Signaling Technology,
Beverly, MA, USA) and anti-Ki-67 (DAKO A/S, Glostrup,
Denmark) antibodies, respectively. Cells were cytospun on
poly-L-lysine-coated glass slides at 1500 rpm for 3min, fixed
with 10% formalin for 10min, and treated with 0.25% Triton
X-100 solution for 10min. After treatment with peroxidase
blocking solution (DAKO), cells were incubated with anti-
FoxO3a and anti-Ki-67 antibodies diluted 1:100 and treated
with the ChemMate EnVision kit (DAKO). Diaminobenzi-
dine (DAKO) was used as a chromogen. As the negative
control, staining was performed in the absence of primary
antibody.
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Mice and Xenograft Transplantation
Six- to 8-week-old female nonobese diabetic/severe com-
bined immunodeficient (NOD/SCID) mice were purchased
from Charles River Laboratories Japan and kept under spe-
cific pathogen-free conditions. Before xenotransplantation,
the mice were deeply anesthetized. All animal experiments
were performed according to the guidelines of the Osaka
University Animal Center and approved by the Institutional
Review Board Committee of Animal Experiments. In this
study, the total number of cells was prepared at 1 105. Cells
were suspended in 0.2ml Matrigel (BD Biosciences) and were
subcutaneously injected into the flank on the left and right
sides, respectively, of the same animal. Tumor volume was
estimated using the formula: (width)2 (length)/2, accord-
ing to the report by Meyer-Siegler et al.29
Knocked-Down of ALDH1A1 Expression
For knocked-down of ALDH1A1 gene expression, cells were
transfected with FlexiTube GeneSolution for ALDH1A1
(Qiagen, 4 types of siRNA were provided) or control All Star
Negative Control siRNA (Qiagen). The knocked-down of
ALDH1A1 gene was evaluated by qRT-PCR as described
above.
Cell Cycle Analysis
The DNA contents of cells were measured by the PI staining
method. Cells (1 106) were washed with PBS and fixed with
70% ethanol for at least 20min at 4 1C. Fixed cells were
rinsed twice with PBS, and re-suspended in PBS containing
0.6% Triton X-100, 0.1 mg/ml RNase A (Sigma) and PI, then
incubated in the dark at room temperature for 20min.
Stained cells were analyzed by a FACS Canto II (BD Bio-
sciences) and CellQuest analysis software.
Statistical Analysis
Statistical analyses were performed using Student’s t-tests.
Data are presented as the mean±standard error (s.e.) of
at least three experiments and P values of less than 0.05 were
considered to be statistically significant.
RESULTS
Characteristics of ALDH-High Cells
ALDH activity was examined using the Aldefluor assay in the
HL cell lines L428 and L1236. Both cell lines contained
ALDH-high cells (Figures 1a and b), though there were more
in the L428 cell line than in L1236; thus, hereafter, L428 cells
were the focus of our investigation. CICs are known to yield
both CICs and non-CICs, whereas non-CICs do not yield any
CICs. To examine whether ALDH could be used as a CIC
marker for HL, ALDH-high and -low L428 cells were sorted
and separately cultured. The sorted ALDH-high cells yielded
both ALDH-high and -low populations, whereas ALDH-low
cells yielded substantially fewer ALDH-high cells (Figures 1c
and d).
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Figure 1 ALDH activity in HL cells. The Aldefluor assay was performed with (a) L428 cells and (b) L1236 cells. ALDH-high (box, P6) and ALDH-low (box, P5)
populations of L428 cells were sorted. The sorted cells were cultured separately for several hours and the Aldefluor assay was then repeated with both
(c) ALDH-low and (d) ALDH-high (box) cells.
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To assess their colony formation ability, the sorted ALDH-
high and -low populations were plated in methylcellulose-
containing DMEM supplemented with 15% FCS. The number
of colonies obtained from ALDH-high cells was signi-
ficantly higher than that from ALDH-low cells (Figure 2a).
To examine tumorigenicity in vivo, ALDH-high and -low
cells were injected into the left and right flanks, respectively,
of NOD/SCID mice. At 30 weeks after the injection, a tumor
mass was only found at the injection site of ALDH-high cells;
tumor volumes were 112.5±8.8mm2, 434.0±9.9mm2,
1518.0±46.7mm2, 3045.0±74.2mm2, and 5896.0±31.1mm2
at 30, 32, 34, 36, and 37 weeks, respectively. No tumor was
found at the injection site of ALDH-low cells throughout the
observation period (Figures 2b and c).
To further examine the tumorigenic potential of
ALDH-high cells, the knock-down of ALDH1A1 expression
was performed. Although ALDH1A1 expression was
downregulated in L428 cells (Supplementary Figure 1A), the
ALDH-high population was not completely absent (Supple-
mentary Figure 1B). This suggested that ALDH activity of
L428 cells was attributable not only to ALDH1A1, but also
to other isoforms of ALDH. Therefore, ALDH activity was
not downregulated by conventional knock-down of the
ALDH1A1 gene alone.
Characteristics of the ROS-Low Population of L428 Cells
In addition to high ALDH activity, ROS-degradation ability
is one of the characteristics of CICs. Previously, we demon-
strated that the ROS contents in a small portion of L1236
cells persisted at a low level after culture.26 This ROS-de-
grading population of L1236 cells was tumorigenic and small
in cell size. To examine whether this observation was ap-
plicable to L428, cells were stained with CM-H2DCFDA, and
cells with high levels of ROS fluoresced green. When stained
with CM-H2DCFDA, a proportion of L428 S cells had no or
faint green fluorescence, indicating that an ROS-degrading
population was also present among L428 cells (Figures 3a
and b).
Figure 3 ROS concentration in L428 cells. (a) ROS-high cells were
stained in green and dead cells are in red. Viable ROS-low cells are
indicated by arrows. (b) Proportion of ROS/PI-low cells. S; single nucleus.
M; multinucleus. Data are presented as the mean±s.e. of three
experiments. *P o 0.05, Student’s t-test.
Figure 2 In vitro colony formation assay and xenotransplantation
into NOD/SCID mice. (a) The number of colonies that developed during
culture of ALDH-low and -high cells in methylcellulose is shown. Data are
presented as the mean±s.e. of three experiments. *P o 0.05, Student’s
t-test. (b) Xenotransplantation of ALDH-high and -low L428 cells into
NOD/SCID mice. ALDH-high and -low cells were injected into the left and
right flanks, of NOD/SCID mice, respectively. A tumor mass was found at the
injection site of ALDH-high cells (left), but not of ALDH-low cells (right).
(c) Tumor volume is presented as the mean±s.e. of three experiments.
*P o 0.05, Student’s t-test.
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It is known that ROS and FoxO3a levels are inversely
correlated. As was previously reported in L1236 cells, sorted
ROS-low L428 cells (Figure 4a) expressed higher levels of
FoxO3a mRNA than ROS-high cells (Figure 4b). Immuno-
cytochemically, FoxO3a expression was mostly confined to a
portion of S cells (Figures 4c and d). These findings indicated
that some S cells with in the L428 cell population expressed
a higher level of FoxO3a and expelled ROS efficiently.
Bcl-6 is reported to suppress ROS production in B-non
HL.30 To examine whether this is the case in HL, Bcl-6
expression levels were examined in ROS-high and -low L1236
and L428 cells. No significant difference in Bcl-6 expression
was detected between these two populations, indicating that
Bcl-6 was not involved in the regulation of ROS production,
at least in L1236 and L428 cells (Figure 4e).
To assess the colony formation ability of ROS-low and
-high cells, the two cell populations were plated separately.
The number of colonies obtained from ROS-low cells
was significantly higher than that from ROS-high cells
(Figure 5a). To examine tumorigenicity in vivo, ROS-low and
-high cells were injected into the left and right flanks of
NOD/SCID mice, respectively. At 12 weeks post-injection,
a tumor mass was only found at the injection site of
ROS-low cells; tumor volumes were 210.0±9.9mm2,
1894.5±92.3mm2, and 4992.0±135.8mm2 at days 98, 119,
and 133, respectively. Tumors derived from ROS-low cells
consisted of both S and M cells. No tumor was found at the
injection site of ROS-high cells throughout the observation
period (Figures 5b and c).
Immunophenotype and Immunoglobulin Gene
Structure of ALDH-High and-Low Populations
The immunophenotypes of ALDH-high and ALDH-low
populations of L428 cells were examined. The ALDH-high
population contained a greater number of CD30-negative
cells than the ALDH-low population (Figure 6a). A small
number of CD20-positive cells was found in the ALDH-high,
but not in the ALDH-low, population (Figure 6a). The
proportion of CD27-positive cells in the ALDH-high popu-
lation was comparable to that in the ALDH-low population.
Restricted expression of the Ig light chain (Igl) was found in
the ALDH-high population (Figure 6a), but not in the
ALDH-low population.
Next, the Ig gene sequence was compared between ALDH-
high and -low populations. The capillary electrophoretic
Figure 4 Expression of FoxO3a in ROS-low and ROS-high L428 cells. (a) Flow cytometric analysis of CM-H2DCFDA staining. ROS-low and ROS-high
populations were gated. (b) Real-time qRT-PCR for FoxO3a expression in ROS-low and -high cells. (c) Immunocytochemistry of FoxO3a in L428 cells ( 400).
(d) Proportion of FoxO3a-positive cells in ROS-low and -high cell populations. (e) Real-time qRT-PCR for Bcl-6 expression in ROS-low and -high cells.
Data are presented as the mean±s.e. of three experiments. *P o 0.05, Student’s t-test.
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profiles of k chain amplification were comparable between
these two populations (Figure 6b).
Relationship between ROS-Low and ALDH-High
Populations
The correlation between ROS-degradation and ALDH acti-
vity was examined. In both L1236 and L428 cells, the level of
ALDH1A1 expression was significantly higher in ROS-low
than in ROS-high cells (Figures 7a and b). The expression of
another isoform of ALDH, ALDH3A1, was also examined,
but no significant difference was detected between ROS-low
and -high cells (Supplementary Figure 2). Immunocyto-
chemically, the proportion of FoxO3a-positive cells among
L1236 and L428 cells was higher in ALDH-high than in
Figure 5 In vitro colony formation assay and xenotransplantation into
NOD/SCID mice. (a) In vitro colony formation assay. The number of colonies
that developed during culture of ROS-low and -high cells in methylcellulose
is shown. (b) Xenotransplantation of ROS-low and -high L428 cells into
NOD/SCID mice. ROS-low and -high cells were injected into the left and
right flanks of NOD/SCID mice, respectively. A tumor mass was found at
the injection site of ROS-low cells, but not of ROS-high cells. Resected
tumor at the injection site of ROS-low cells (left). No tumor was found at the
injection site of ROS-high cells (right). (c) Tumor volumes derived from mice
injected with ROS-low and -high cells. The data are presented as the
mean±s.e. of three experiments. *P o 0.05, Student’s t-test.
Figure 6 Immunophenotype and immunoglobulin gene sequence of
ALDH-high and ALDH-low populations of L428 cells. (a) The surface
expression levels of CD20, CD30, CD27, l chain, and k chain were examined.
(b) Capillary electrophoretic profiles of amplified products from
immunoglobulin k chain, following the BIOMED-2 protocol.
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ALDH-low cells, as in the case of ROS-low cells shown
in Figure 4d (Figure 7c). In terms of proliferative activity,
although the proportion of Ki-67-positive cells was signifi-
cantly higher in ROS-low than in ROS-high populations,
the proportion of Ki-67-positive cells was not significantly
different between ALDH-high and -low cells (Figures 7d
and e).
To examine cell cycle status, the proportions of G0/G1,
S, G2/M, and sub-G0 cells were evaluated by flow cytometry.
Immediately after sorting, ROS-low cells had more cells in
the G0/G1 phase than ROS-high cells (Figures 8a and b). In
contrast, the proportion of cells in the G0/G1 phase was not
significantly different between ALDH-high and -low cells
(Figures 8c and d).
The change in cell cycle status during culture of sorted cells
was also examined. Twenty-four hours after the start of
culture of sorted ROS-low cells, the proportion of G0/G1
phase cells decreased, whereas those in the G2/M phase
increased (Figure 8a). The number of ROS-high cells in the
G0/G1 phase did not change, whereas an increase of sub-G0
phase cells and the appearance of apoptosis were found
(Figure 8b). Increased numbers of sub-G0 cells were not
detected in ROS-low cells. The proportion of sub-G0 cells
increased in ALDH-low cells (Figure 8c). Approximately half
of the ALDH-low cells were in the sub-G0 phase, which was
significantly more than that found in ALDH-high cells
(Figure 8d).
Figure 7 Real-time qRT-PCR of ALDH1A1 expression in ROS-low and ROS-high HL cells. ALDH1A1 expression was determined in (a) L428 and (b) L1236 cell
lines. (c) Proportion of FoxO3a-positive cells in the ALDH-low and -high populations. (d, e) Proportion of Ki-67 positive cells in ROS-low and -high
(d), or ALDH-low and -high cells (e). Data are presented as the mean±s.e. of three experiments. *P o 0.05, Student’s t-test.
Figure 8 Cell cycle analysis. The cell cycle statuses of (a) ROS-low,
(b) ROS-high, (c) ALDH-low, and (d) ALDH-high cells were determined after
24 h of culture.
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DISCUSSION
Historically, the origin of neoplastic cells, e.g., RS cells, in
HL has been of great interest. Recent studies analyzing
immunoglobulin gene rearrangement and the fusion patterns
of terminal repeats in Epstein-Barr virus (EBV) in micro-
dissected single cells from HL lesions revealed the mono-
clonality and neoplastic B cell nature of RS and Hodgkin
cells.23,24 Our recent study using the HL cell lines L1236
and L428 revealed that a portion of large cells with a single
nucleus (S cells) that resemble Hodgkin cells have tumori-
genic potential.26 This tumorigenic population expelled
ROS efficiently and maintained ROS at low levels. Since ROS-
degradation is characteristic of CICs, the tumorigenic popu-
lation of S cells was suggested as a candidate CIC of HL.
In addition to ROS-degradation, cells with high ALDH
activity are reported to possess CIC characteristics; the
ALDH-high population is tumorigenic and resistant to
chemotherapy in cancers of the colon, breast, lung, pancreas,
bladder, prostate, and ovary.10–20 In the present study, the
ALDH-high population of HL was examined. ALDH-high
cells efficiently formed colonies and yielded both ALDH-high
and -low populations. In contrast, ALDH-low cells rarely
yielded ALDH-high cells. These findings were in agreement
with the study by Jones et al27 that indicated the circulating B
cell population with high ALDH expression in HL patients
was tumorigenic. That same study also reported that
tumorigenic potential was detected in the CD30-negative,
CD20-positive, and Ig light chain-expressing population of
HL. Consistent with this, the ALDH-high population con-
tained CD30-negative, CD20-positive, and l chain-expres-
sing cells more abundantly than the ALDH-low population.
ALDH-high cells, in particular less differentiated cells, may
possess characteristics of CICs in HL, similar to that seen in
cancers of other organs.
CICs are known to expel ROS efficiently and possess high
ALDH activity.9–20 However, to our knowledge, it was unclear
whether ROS-low cells and ALDH-high cells merely shared
CIC characteristics or belonged to the same population of cells.
Therefore, this study examined ALDH activity in ROS-low and
-high cells. ALDH expression levels were significantly higher in
ROS-low than in -high cells. FoxO3a activates various ROS-
expelling enzymes, and its expression level is reported to be
high in ROS-low cells.26,31,32 The present study revealed that
the proportion of FoxO3a expressing cells was higher in the
ALDH-high than in the ALDH-low population. These findings
suggest that the ALDH-high and ROS-low populations appear
to be identical, or, at least, overlapped.
The proportion of Ki-67-positive cells was significantly
higher in ROS-low than -high cells, whereas ALDH-high and
-low populations contained similar proportions of Ki-67-
positive cells. Upon cell cycle analysis, the proportion of cells
in the G0/G1 phase was higher in ROS-low than -high cells.
In contrast, no difference in the proportion of cells in the
G0/G1 phase was found between ALDH-high and -low cells.
These findings indicated that the ROS-low population was
different from ALDH-high cells with regard to cell cycle
status. As CICs are known to be relatively quiescent in several
tumors,16,33,34 ROS-low cells are more likely to be CIC than
ALDH-high populations. Further studies on CICs in various
types of malignancies, other than HL, will provide insight on
the precise relationship between ROS-expelling and high
ALDH activities.
Moreb et al35 recently reported that the knock-down of
ALDH1A1 and ALDH3A1 resulted in decreased proliferative
activity of lung adenocarcinoma cell lines. Since the level of
ALDH did not affect the proliferative activity of Hodgkin
lymphoma cell lines in the present study, the effect of ALDH
may differ among cancer cell types. In fact, high ALDH
activity is a poor prognostic indicator for breast, prostate,
bladder, and uterine cancers, but a favorable indicator for
ovary cancer.36,37 Further studies are necessary to elucidate
the mechanism of ALDH function in cancer cells.
The ROS-low population in a quiescent state efficiently
formed colonies in vitro, although rapid proliferation of cells
might be necessary for colony formation. When compared to
the cell cycle status just after sorting, the ROS-low population
showed a dramatic increase in the number of G2/M phase
cells after 24 h of culture. In contrast, the proportion of
G2/M phase cells decreased and apoptosis occurred in the
ROS-high population. The lower number of colonies found
during the culture of ROS-high cells compared to -low cells
might be due to low proliferative potential and vulnerability
to apoptosis. ALDH-high cells had a similar ability for
efficient colony formation as ROS-low cells. After 24 h in
culture, the proportion of apoptotic cells was lower in the
ALDH-high than in the ALDH-low population. Anti-apop-
totic potential may be attributable to the ability for efficient
colony formation in the ALDH-high population.
Taken together, ALDH-high and ROS-low populations
may be candidate CICs; however, they have distinct cell cycle
profiles, indicating that CICs may be comprised of cells with
heterogeneous characteristics.
Supplementary Information accompanies the paper on the Laboratory
Investigation website (http://www.laboratoryinvestigation.org)
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